Crinetics Pharmaceuticals (CRNX) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.38
-1.23
-1.09
-0.94

Details

Expected EPS
-1.221429
Actual EPS
-1.23
Surprise EPS
-0.01
Surprise Percent
-0.7%

Description

⁨Crinetics Pharmaceuticals⁩ (⁦CRNX⁩) has reported earnings of ⁦-1.23⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts